Andrew von Eschenbach | |
|---|---|
 | |
| 20th Commissioner of Food and Drugs | |
| In office December 13, 2006 – January 20, 2009 | |
| President | George W. Bush |
| Preceded by | Lester Mills Crawford |
| Succeeded by | Margaret A. Hamburg |
| 12th Director of the National Cancer Institute | |
| In office January 22, 2002 – June 10, 2006 | |
| President | George W. Bush |
| Preceded by | Richard D. Klausner |
| Succeeded by | John E. Niederhuber |
| Personal details | |
| Born | October 30, 1941 Philadelphia, Pennsylvania, U.S. |
| Spouse | Madelyn von Eschenbach |
| Children | Andrew von Eschenbach, Amanda von Eschenbach, Warren von Eschenbach, Christian von Eschenbach |
| Alma mater | St. Joseph's University, Georgetown University School of Medicine |
Andrew C. von Eschenbach (born October 30, 1941) was the Commissioner of the United States Food and Drug Administration from 2006 to 2009. He became acting Commissioner on September 26, 2005, after the resignation of his predecessor Lester Crawford, and was confirmed as Commissioner by the Senate on December 7, 2006.[1][2] He was previously the 12th director of the National Cancer Institute.
Von Eschenbach currently serves on the board of directors of BioTime, a biotechnology company helmed by CEO Michael D. West.[3] He also serves as a director of Viamet Pharmaceuticals.[4]
- ^ U.S. Congress (7 December 2006). "Executive Session". Congressional Record. 152 (134): S11404–29, S11447–51. Retrieved 2006-12-12.
- ^ Senate Vote No. 274
- ^ "BioTime, Inc. Appoints Andrew C. von Eschenbach, M.D. to its Board of Directors". BusinessWire Press Release. November 9, 2011.
- ^ Viamet Pharmaceuticals web site, archived from the original on 2014-06-20